FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

FOCUS ON RESEARCH Previous Volume 358:2540-2543 June 12, 2008 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ehrlich, H. J. PubMed Citation

The quest for a fully immunogenic vaccine against influenza H5N1 viruses has gone on for more than 10 years, since this family of potentially pandemic viruses emerged as a cause of human disease in Hong Kong in 1997. H5N1 has caused 381 human cases of influenza, with a mortality rate exceeding 60%. H5 strains have now been found in birds throughout much of the world (though not yet in the Americas), and human illness has occurred in 14 countries throughout Asia and in northern Africa.¹ The much-feared rapid spread through and between communities, however, has not occurred. Aside from small . . . [Full Text of this Article]

Source Information

Dr. Wright is a professor of pediatrics at Dartmouth Medical School, Hanover, NH.

This article has been cited by other articles:

• (2008). Whole-Virus H5N1 Vaccine Trial. JWatch Infect. Diseases 2008: 1-1 [Full Text]